BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Isolagen, Inc. 

2500 Wilcrest, 5th Floor

Houston  Texas  77042  U.S.A.
Phone: 713-780-4754 Fax: 713-781-9396


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Isolagen, Inc. (ILE) Reorganizes as Fibrocell Science, Inc. 10/6/2009 7:34:29 AM    More...
Isolagen, Inc. (ILE) Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 6/22/2009 10:28:52 AM    More...
US Biotech Isolagen, Inc. (ILE) Files for Bankruptcy Protection 6/16/2009 7:37:21 AM    More...
FDA Accepts Isolagen, Inc. (ILE)'s Biologics License Application for Full Review 5/8/2009 11:48:31 AM    More...
Isolagen, Inc. (ILE) Receives Bridge Financing to Allow it to Seek Debtor-in-Possession Financing in Connection With a Possible Filing Under Chapter 11 of the United States Bankruptcy Code 5/7/2009 7:22:36 AM    More...
Isolagen, Inc. (ILE) Looks For Savior As Cash Flow Dwindles 3/30/2009 7:08:06 AM    More...
Isolagen, Inc. (ILE) Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration 3/9/2009 10:38:30 AM    More...
Isolagen, Inc. (ILE) Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 3/5/2009 9:01:34 AM    More...
Isolagen, Inc. (ILE) Provides Analysis of Data from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles 10/23/2008 10:23:35 AM    More...
Isolagen, Inc. (ILE) Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study 10/21/2008 11:11:24 AM    More...
12345678910...